SI2516435T1 - Inhibitorji AKT-aktivnosti - Google Patents
Inhibitorji AKT-aktivnostiInfo
- Publication number
- SI2516435T1 SI2516435T1 SI201030774T SI201030774T SI2516435T1 SI 2516435 T1 SI2516435 T1 SI 2516435T1 SI 201030774 T SI201030774 T SI 201030774T SI 201030774 T SI201030774 T SI 201030774T SI 2516435 T1 SI2516435 T1 SI 2516435T1
- Authority
- SI
- Slovenia
- Prior art keywords
- inhibitors
- akt activity
- akt
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0922589.7A GB0922589D0 (en) | 2009-12-23 | 2009-12-23 | Pharmaceutical compounds |
| EP10800980.4A EP2516435B8 (en) | 2009-12-23 | 2010-12-23 | Inhibitors of akt activity |
| PCT/GB2010/002329 WO2011077098A1 (en) | 2009-12-23 | 2010-12-23 | Inhibitors of akt activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2516435T1 true SI2516435T1 (sl) | 2014-12-31 |
Family
ID=41716932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201030774T SI2516435T1 (sl) | 2009-12-23 | 2010-12-23 | Inhibitorji AKT-aktivnosti |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9221838B2 (sl) |
| EP (1) | EP2516435B8 (sl) |
| JP (1) | JP5923043B2 (sl) |
| KR (1) | KR20140015157A (sl) |
| CN (1) | CN102791708B (sl) |
| AU (1) | AU2010334591C1 (sl) |
| BR (1) | BR112012015677A2 (sl) |
| CA (1) | CA2783340C (sl) |
| CY (1) | CY1115686T1 (sl) |
| DK (1) | DK2516435T3 (sl) |
| ES (1) | ES2503794T3 (sl) |
| GB (1) | GB0922589D0 (sl) |
| HK (1) | HK1171013A1 (sl) |
| IL (1) | IL220153A (sl) |
| MX (1) | MX2012007274A (sl) |
| NZ (1) | NZ600453A (sl) |
| PL (1) | PL2516435T3 (sl) |
| PT (1) | PT2516435E (sl) |
| RU (1) | RU2579513C2 (sl) |
| SG (1) | SG181517A1 (sl) |
| SI (1) | SI2516435T1 (sl) |
| WO (1) | WO2011077098A1 (sl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201205164D0 (en) * | 2012-03-23 | 2012-05-09 | Almac Discovery Ltd | Pharmaceutical compounds |
| CN107207472B (zh) * | 2014-12-23 | 2020-08-14 | 卑尔根生物股份公司 | Akt激酶的抑制剂 |
| US10323044B2 (en) * | 2015-02-27 | 2019-06-18 | Taiho Pharmaceutical Co., Ltd. | Crystal of imidazo-oxazine, pharmaceutical composition containing said crystal, and method for producing said crystal |
| WO2019051063A1 (en) | 2017-09-07 | 2019-03-14 | Augusta University Research Institute, Inc. | SPECIFIC AKT3 ACTIVATOR AND USES THEREOF |
| GB201603779D0 (en) | 2016-03-04 | 2016-04-20 | Mission Therapeutics Ltd | Novel compounds |
| US11208478B2 (en) | 2016-08-07 | 2021-12-28 | The Wistar Institute Of Anatomy And Biology | Methods of detecting and treating a tumor expressing pT346 PDK1 |
| CN111132972A (zh) * | 2017-06-22 | 2020-05-08 | 克拉德夫制药有限公司 | 人sting的小分子调节剂 |
| GB2600384A (en) | 2020-09-30 | 2022-05-04 | Vaderis Therapeutics Ag | Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996015128A2 (en) * | 1994-11-14 | 1996-05-23 | Warner-Lambert Company | 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
| TWI301760B (en) * | 2004-02-27 | 2008-10-11 | Merz Pharma Gmbh & Co Kgaa | Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
| WO2006065601A2 (en) * | 2004-12-15 | 2006-06-22 | Merck & Co., Inc. | Inhibitors of akt activity |
| MX2007015578A (es) * | 2005-06-10 | 2008-03-06 | Merck & Co Inc | Inhibidores de la actividad akt. |
| ES2400695T3 (es) * | 2006-07-17 | 2013-04-11 | Amgen Inc. | Derivados de quinazolina y piridopirimidina como inhibidores de la cinasa p38 |
| AR064010A1 (es) | 2006-12-06 | 2009-03-04 | Merck & Co Inc | Inhibidores de la actividad de la akt |
| EP2120951A4 (en) | 2006-12-06 | 2012-02-15 | Merck Sharp & Dohme | INHIBITORS OF AKT ACTIVITY |
| US7999107B2 (en) * | 2007-01-31 | 2011-08-16 | Merck Sharp & Dohme Corp. | Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators |
| AU2009255329A1 (en) | 2008-06-03 | 2009-12-10 | Msd K.K. | Inhibitors of Akt activity |
| EP2303269B1 (en) * | 2008-06-03 | 2014-07-30 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
-
2009
- 2009-12-23 GB GBGB0922589.7A patent/GB0922589D0/en not_active Ceased
-
2010
- 2010-12-23 US US13/517,219 patent/US9221838B2/en active Active
- 2010-12-23 NZ NZ600453A patent/NZ600453A/xx not_active IP Right Cessation
- 2010-12-23 SG SG2012041232A patent/SG181517A1/en unknown
- 2010-12-23 DK DK10800980.4T patent/DK2516435T3/da active
- 2010-12-23 CN CN201080059321.9A patent/CN102791708B/zh active Active
- 2010-12-23 SI SI201030774T patent/SI2516435T1/sl unknown
- 2010-12-23 BR BRBR112012015677-2A patent/BR112012015677A2/pt not_active Application Discontinuation
- 2010-12-23 WO PCT/GB2010/002329 patent/WO2011077098A1/en active Application Filing
- 2010-12-23 JP JP2012545434A patent/JP5923043B2/ja active Active
- 2010-12-23 ES ES10800980.4T patent/ES2503794T3/es active Active
- 2010-12-23 CA CA2783340A patent/CA2783340C/en not_active Expired - Fee Related
- 2010-12-23 AU AU2010334591A patent/AU2010334591C1/en not_active Ceased
- 2010-12-23 PL PL10800980T patent/PL2516435T3/pl unknown
- 2010-12-23 KR KR1020127019033A patent/KR20140015157A/ko not_active Application Discontinuation
- 2010-12-23 MX MX2012007274A patent/MX2012007274A/es active IP Right Grant
- 2010-12-23 EP EP10800980.4A patent/EP2516435B8/en active Active
- 2010-12-23 PT PT108009804T patent/PT2516435E/pt unknown
- 2010-12-23 RU RU2012131115/04A patent/RU2579513C2/ru not_active IP Right Cessation
-
2012
- 2012-06-04 IL IL220153A patent/IL220153A/en not_active IP Right Cessation
- 2012-11-16 HK HK12111698.8A patent/HK1171013A1/xx not_active IP Right Cessation
-
2014
- 2014-10-31 CY CY20141100899T patent/CY1115686T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US9221838B2 (en) | 2015-12-29 |
| RU2012131115A (ru) | 2014-01-27 |
| DK2516435T3 (da) | 2014-10-13 |
| AU2010334591B2 (en) | 2014-04-10 |
| WO2011077098A1 (en) | 2011-06-30 |
| NZ600453A (en) | 2013-10-25 |
| CN102791708A (zh) | 2012-11-21 |
| CA2783340C (en) | 2015-11-24 |
| EP2516435B1 (en) | 2014-08-06 |
| US20130116243A1 (en) | 2013-05-09 |
| EP2516435A1 (en) | 2012-10-31 |
| JP5923043B2 (ja) | 2016-05-24 |
| PT2516435E (pt) | 2014-11-13 |
| AU2010334591A1 (en) | 2012-06-21 |
| BR112012015677A2 (pt) | 2015-06-30 |
| PL2516435T3 (pl) | 2015-01-30 |
| JP2013515710A (ja) | 2013-05-09 |
| RU2579513C2 (ru) | 2016-04-10 |
| EP2516435B8 (en) | 2014-10-15 |
| CN102791708B (zh) | 2016-03-02 |
| CY1115686T1 (el) | 2017-01-25 |
| SG181517A1 (en) | 2012-07-30 |
| IL220153A0 (en) | 2012-07-31 |
| IL220153A (en) | 2015-05-31 |
| ES2503794T3 (es) | 2014-10-07 |
| AU2010334591C1 (en) | 2014-07-31 |
| WO2011077098A9 (en) | 2012-04-19 |
| CA2783340A1 (en) | 2011-06-30 |
| HK1171013A1 (en) | 2013-03-15 |
| GB0922589D0 (en) | 2010-02-10 |
| KR20140015157A (ko) | 2014-02-06 |
| MX2012007274A (es) | 2012-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2391623A4 (en) | INHIBITORS OF AKT ACTIVITY | |
| EP2413932A4 (en) | INHIBITORS OF AKT ACTIVITY | |
| EP2303269A4 (en) | HAMMER OF ACT ACTIVITY | |
| EP2406250A4 (en) | HAMMER OF ACT ACTIVITY | |
| ZA201700326B (en) | Inhibitors of beta-secretase | |
| HK1132676A1 (en) | Inhibitors of akt activity akt | |
| IL209488A0 (en) | Inhibitors of akt activity | |
| EP2114388A4 (en) | INHIBITORS OF AKT'S ACTIVITY | |
| HK1159102A1 (en) | Inhibitors of ssao activity ssao | |
| HK1137758A1 (en) | Inhibitors of akt activity akt | |
| HK1171390A1 (en) | Heparanase activity inhibitor | |
| EP2405756A4 (en) | HAMMER OF ACT ACTIVITY | |
| EP2306825A4 (en) | HAMMER OF ACT ACTIVITY | |
| EP2303852A4 (en) | ACTIVITY INHIBITORS AKT | |
| HK1171013A1 (en) | Inhibitors of akt activity akt | |
| EP2134175A4 (en) | HAMMER OF ACT ACTIVITY | |
| ZA201206456B (en) | Uses of dgati inhibitors | |
| HK1171624A1 (en) | Inhibitors of cognitive decline | |
| HK1167323A1 (en) | Inhibitors of cognitive decline | |
| EP2120951A4 (en) | INHIBITORS OF AKT ACTIVITY | |
| EP2579872A4 (en) | HAMMER OF ACT ACTIVITY | |
| EP2303277A4 (en) | HAMMER OF ACT ACTIVITY | |
| EP2303017A4 (en) | HAMMER OF ACT ACTIVITY | |
| EP2303258A4 (en) | ACTIVITY INHIBITORS AKT | |
| EP2513059A4 (en) | HAMMER OF ACT ACTIVITY |